|
rs498005
|
|
|
0.010 |
GeneticVariation |
BEFREE |
<b>Results:</b> C allele of rs498005 was significantly correlated with increased risk of AF (OR = 1.412, 95%CI = 1.012-1.970), and the association still exited after adjustment by age, gender, the status of smoking and drinking, histories of diabetes, hyperlipidaemia and myocardial infarction (adjusted OR = 1.473, 95%CI = 1.043-2.081).
|
31315459 |
2019 |
|
rs1256049
|
|
|
0.010 |
GeneticVariation |
BEFREE |
1082A>G (rs1256049) and 1730A>G (rs4986938) showed no statistical association with hyperlipidemia.
|
19927160 |
2010 |
|
rs4986938
|
|
|
0.010 |
GeneticVariation |
BEFREE |
1082A>G (rs1256049) and 1730A>G (rs4986938) showed no statistical association with hyperlipidemia.
|
19927160 |
2010 |
|
rs1048943
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Hyperlipidemia could modulate the effect of CYP1A1 rs1048943 on the periodontal status of GAgP.
|
31032950 |
2019 |
|
rs200960801
|
|
|
0.010 |
GeneticVariation |
BEFREE |
1082A>G (rs1256049) and 1730A>G (rs4986938) showed no statistical association with hyperlipidemia.
|
19927160 |
2010 |
|
rs121918392
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).
|
12069856 |
2002 |
|
rs1341991169
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).
|
12069856 |
2002 |
|
rs738409
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Accordingly, the naringenin-betaine cocrystals showed improved anti-hyperlipidemia effects on the C57 BL/6J PNPLA3 I148M transgenic mouse hyperlipidemia model.
|
30771018 |
2019 |
|
rs2523608
|
|
|
0.010 |
GeneticVariation |
BEFREE |
After stratification, hyperlipidemia remained a risk factor in women (OR = 4.735, 95% CI: 3.375⁻6.643) and men (OR = 3.640, 95% CI: 2.916⁻4.544) with rs2523608 GG genotype.
|
30934611 |
2019 |
|
rs174537
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among four SNPs, only rs174537G>T differed in allele frequencies between controls and CAD patients after adjustment for age, BMI, cigarette smoking, alcohol consumption, hypertension, diabetes mellitus, and hyperlipidemia (P=0.017).
|
21040914 |
2011 |
|
rs679899
|
|
|
0.010 |
GeneticVariation |
BEFREE |
APOB polymorphisms were identified using mass spectrometry, and five single nucleotide polymorphisms (rs1042034, rs2163204, rs512535, rs676210, and rs679899) and serum lipids were further analyzed. rs1042034 and rs676210 were significantly associated with HL (P<0.05).
|
28902930 |
2017 |
|
rs2241883
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects.
|
25663234 |
2015 |
|
rs3816873
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects.
|
25663234 |
2015 |
|
rs694539
|
|
|
0.010 |
GeneticVariation |
BEFREE |
At present, more than 200 <i>NNMT</i> single nucleotide polymorphisms (SNPs) have been identified in the databases of the human genome projects; however, the association between rs694539 variation and hyperlipidemia has not been reported yet, and whether there are any SNPs in <i>NNMT</i> significantly associated with hyperlipidemia is still unclear.
|
27999813 |
2016 |
|
rs140808909
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Characterization of apolipoprotein E7 (Glu(244)-->Lys, Glu(245)--->Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis.
|
9925654 |
1999 |
|
rs879254840
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Characterization of apolipoprotein E7 (Glu(244)-->Lys, Glu(245)--->Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis.
|
9925654 |
1999 |
|
rs573658040
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Digestion with BbvI or Fnu4HI allows for rapid restriction isotyping for the rare apolipoprotein E R145C mutation associated with hyperlipidemia.
|
7735921 |
1995 |
|
rs769455
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Digestion with BbvI or Fnu4HI allows for rapid restriction isotyping for the rare apolipoprotein E R145C mutation associated with hyperlipidemia.
|
7735921 |
1995 |
|
rs1137101
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Effects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia.
|
26984935 |
2017 |
|
rs6214
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Elders with GG genotype of rs6214 and AC or CC genotypes of rs2854744 had a 3.18-fold (95% CI 1.02-9.89) risk of having low ASMI compared with those with the AA and AA genotype, after adjusting for age, gender, smoking, exercise, hyperlipidemia, and albumin level.
|
25548030 |
2015 |
|
rs2854744
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Elders with GG genotype of rs6214 and AC or CC genotypes of rs2854744 had a 3.18-fold (95% CI 1.02-9.89) risk of having low ASMI compared with those with the AA and AA genotype, after adjusting for age, gender, smoking, exercise, hyperlipidemia, and albumin level.
|
25548030 |
2015 |
|
rs662799
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Excess risk for low HDL-C and hyperlipidemia was associated with rs662799 genotype alleles of APOA5 SNPs in older Chinese adults.
|
29758349 |
2018 |
|
rs717620
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Female Chinese patients with hyperlipidemia carrying rs717620 GA/AA genotypes might have reduced benefit from simvastatin treatment.
|
30024814 |
2018 |
|
rs1805087
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Further study is needed to confirm the role of HHcy and MS A2756G mutation in the development of hyperlipidemia.
|
19263808 |
2008 |
|
rs2228314
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Further work is necessary to confirm the role of 1784G>C in the development of hyperlipidemia.
|
15547298 |
2005 |